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Summary: There is strong interest in conducting comparative effectiveness research (CER) in electronic medical
records (EMR) to evaluate treatment strategies among real-world patients. Inferring causal effects in EMR data,
however, is challenging due to the lack of direct observation on pre-specified gold-standard outcomes, in addition to
the observational nature of the data. Extracting gold-standard outcomes often requires labor-intensive medical chart
review, which is unfeasible for large studies. While one may impute outcomes and estimate average treatment effects
(ATE) based on imputed data, naive imputations may lead to biased ATE estimators. In this paper, we frame the
problem of estimating the ATE in a semi-supervised learning setting, where a small set of observations is labeled
with the true outcome via manual chart review and a large set of unlabeled observations with features predictive
of the outcome are available. We develop an imputation-based approach for estimating the ATE that is robust to
misspecification of the imputation model. This allows information from the predictive features to be safely leveraged
to improve the efficiency in estimating the ATE. The estimator is additionally doubly-robust in that it is consistent
under correct specification of either an initial propensity score model or a baseline outcome model. We show that it
is locally semiparametric efficient under an ideal semi-supervised model where the distribution of unlabeled data is
known. Simulations exhibit the efficiency and robustness of the proposed method compared to existing approaches in
finite samples. We illustrate the method to compare rates of treatment response to two biologic agents for treating
inflammatory bowel disease using EMR data from Partner’s Healthcare.
Key words: Causal inference; Double-robustness; Missing data; Propensity score; Robust imputation, Semipara-
metric efficiency; Surrogate outcomes.
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1. Introduction
Electronic medical records (EMR) aggregate rich patient-level data that are routinely col-
lected during patient care. Since they include large samples in broad populations, EMRs
have become a valuable data source for conducting comparative effectiveness research (CER)
and identifying optimal treatment strategies among real-world patients (Fiks et al., 2012;
Manion et al., 2012). However, many challenges arise when performing CER using EMR
data (Hersh et al., 2013). Beyond the usual issue of confounding in observational data, a
primary challenge is the lack of direct observation on a true clinical outcome of interest
Y . In contrast with clinical trials or traditional observational studies, EMR data are not
collected to evaluate any specific pre-specified outcome. This is frequently ignored, whereby
researchers often explicitly or implicitly rely on “surrogate variables” W abstracted from
codified (e.g. billing codes) or narrative (e.g. physician notes) data to approximate Y with
some imputed outcome Y † = g(W). But the accuracy of Y † in approximating Y is usually
unclear, and reliance on naive imputations Y † can lead to biased estimates of the average
treatment effect (ATE) on the actual outcome of interest Y .
To address this issue, EMR studies often undertake a manual chart review process by
domain experts to label records with a “gold-standard” Y . But labeling is a costly and time-
consuming process, which is effectively unfeasible when scaling a study up to a large sample.
An alternative approach used in practice is to label a relatively small number of records and
use the labeled data L to build an imputation model for Y based on features extracted
automatically from the EMR, including W (Ananthakrishnan et al., 2016). This approach
is attractive because it uses Y to build the imputation model and avoids comprehensive
labeling of all records. But it remains unclear when a resulting estimator of the ATE will be
valid or efficient, especially under possible misspecification of the imputation model.
To the best of our knowledge, there have been no methods developed for this problem in the
context of EMR data. This problem can be cast in terms of surrogate outcomes data, where
W can be regarded as surrogates for Y and L can be regarded as a validation sample.
A variety of methods have been developed in this data setting for estimating regression
parameters (Pepe, 1992; Reilly and Pepe, 1995; Chen, 2000; Chen and Chen, 2000) and
solutions to estimating equations (Chen et al., 2003, 2008). These methods tend to assume a
univariate surrogate with low dimensional baseline covariates X and have not been adapted to
estimate causal effects in observational data. More generally, this problem can be regarded as
a missing data problem in which Y is missing in the large set of unlabeled data U , for which
semiparametric efficiency theory can potentially be applied (Robins et al., 1994, 1995; Robins
and Rotnitzky, 1995). This approach has been used to develop robust and efficient estimators
of the ATE in clinical trial settings with availability of surrogates (Davidian et al., 2005) and
observational data with missingness in variables besides Y (Williamson et al., 2012; Zhang
et al., 2016). But these methods assume the proportion of missingness is bounded away from
0, whereas in the EMR setting, L is always so much smaller than U that the proportion
of missingness should be regarded as tending to 0 asymptotically. This in turn changes
the semiparametric efficiency considerations. Moreover, these methods involve parametric
modeling of propensity score (PS) and outcome models, and typical implementations based
on logistic and linear regression models have poor performance if they are misspecified or if
the number of covariates is not small. Other methods for handling missing data in non-EMR
settings based on imputation models (Little and An, 2004; An and Little, 2008) are related
to our proposed approach but do not address estimation of causal treatment effects.
In this paper, we propose a semi-supervised (SS) estimator for the ATE (SSDR) based on
an imputation followed by inverse probability weighting (IPW) that is doubly-robust and
semiparametric efficient. The imputations are constructed such that the resulting estimator
is robust to misspecification of the imputation model, enabling U to be safely used in
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improving estimation. We further employ a double-index propensity score (Cheng et al.,
2017) for additional robustness and efficiency gain. The remainder of the paper is organized
as follows. We formalize the SS estimation problem in Sections 2.1-2.2 and develop the
estimator in Sections 2.3-2.5. A perturbation resampling procedure is proposed in Section
2.6 for inference. Section 3 presents simulations showing the robustness and efficiency of the
proposed estimator, and Section 4 applies the method to compare two biologic therapies
for treating inflammatory bowel disease (IBD) in EMR data from Partner’s Healthcare. We
conclude with some remarks in Section 5. Proofs are deferred to the Web Appendices.
2. Method
2.1 Notations and Semi-Supervised Framework
Let Y denote an outcome that could be modeled by a generalized linear model (GLM),
such as a binary, ordinal, or continuous response, T ∈ {0, 1} a binary treatment, X a px-
dimensional vector of pre-treatment baseline covariates, W a pw-dimensional vector of post-
treatment surrogate variables that are potentially predictive of Y , and V = (WT,XT)T.
The labeled data consists of n independent and identically distributed (iid) observations
L = {(Yi, Ti,VTi )T : i = 1, . . . , n}, while the unlabeled data consists of N iid observations
without Y , U = {(Ti,VTi )T : i = n + 1, . . . , N}, with U ⊥⊥ L . In the SS setting N  n
so that νn = n/N → 0 as n→∞. We assume that the labeled observations were randomly
selected so that Y is missing completely at random (MCAR) from observations in U .
2.2 Target Parameter and Leveraging Unlabeled Data
Let Y (1) and Y (0) denote the counterfactual outcomes had an individual received treatment
or control. Based on the observed data D = L ∪U we want to estimate the ATE:
∆ = E{Y (1)} − E{Y (0)} = µ1 − µ0. (1)
We require the following standard assumptions to identify ∆:
Y = TY (1) + (1− T )Y (0) (2)
(Y (1), Y (0)) ⊥⊥ T | X (3)
pi(x) ∈ [pi, 1− pi] for some pi > 0 when f(x) > 0, (4)
where pi(x) = P(T = 1 | X = x) is the PS and f(x) is the joint density for the covariates. In
the typical setting where the outcome is fully observed, the ATE can be identified through
the g-formula (Robins, 1986):
∆ = E{µ1(X)− µ0(X)} = E
{
I(T = 1)Y
pi(X)
− I(T = 0)Y
1− pi(X)
}
, (5)
where µk(x) = E(Y | X = x, T = k) for k = 0, 1. This suggests the usual estimators based
on averaging the outcome weighted by IPW weights or averaging estimated outcome models.
When the outcome is scarce but surrogates W are available, a further decomposition can
potentially be helpful:
∆ = E [E{ξ1(V) | X, T = 1} − E{ξ0(V) | X, T = 0}]
= E
{
I(T = 1)ξ1(V)
pi(X)
− I(T = 0)ξ0(V)
1− pi(X)
}
,
where ξk(v) = E(Y | V = v, T = k) for k = 0, 1. This form of the g-formula suggests that,
if a consistent estimator for ξk(v) is available, then ∆ can be estimated by first imputing Y
through the ξk(v) estimator and then applying standard IPW or outcome regression methods
to the imputed outcome. However, obtaining a consistent estimator for ξk(v) may not be
feasible without strong modeling assumptions due to the potential high dimensionality of
v and complexity of the functional form of ξk(v). In the following we show that even with
incorrectly specified models for ξk(v), it is still possible to leverage U in estimating ∆
without introducing bias from their misspecification.
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2.3 Robust Imputations
Let Upi = I(T = 1)/pi(X) − I(T = 0)/{1 − pi(X)} denote a utility covariate given pi(x),
assumed momentarily to be known. Suppose we postulate a parametric working model,
possibly misspecified, for ξk(v):
ξT (V) = gξ(γ0 + γ
T
1 h(V) + γ2T + γ3Upi) = gξ(γ
TZpi), (6)
where γ = (γ0,γ
T
1 , γ2, γ3)
T, Zpi = (1,V
T, T, Upi), gξ(·) is a specified link function, and h(·) is a
vector of fixed basis expansion functions that can incorporate nonlinear effects. We estimate
γ as γ̂, the solution to a penalized estimating equation with ridge regularization:
n−1
n∑
i=1
Zpi,i
{
Yi − gξ(γTZpi,i)
}
+ λnγ{−1} = 0, (7)
where γ{−1} denotes the vector γ excluding the first element γ0 and λn = o(n
−1/2) is a
tuning parameter chosen such that γ̂ has n−1/2 convergence rate. In particular, this class of
estimators includes ridge estimators for GLMs based on exponential families with canonical
link functions. Other regularization penalties besides the ridge penalty can also be used, as
long as γ̂ maintains a n−1/2 convergence rate. Using the fact that Y are MCAR, standard
arguments can be used to show that γ̂
p→ γ¯ where γ¯ solves:
E
[
Zpi
{
Y − gξ(γTZpi)
}]
= 0,
with the expectation being taken over the entire population and not restricted only to the
labeled population. Specifically, for Y † = gξ(γ¯TZpi), since Zpi includes Upi this implies that:
E
{
I(T = 1)Y
pi(X)
− I(T = 0)Y
1− pi(X)
}
= E
{
I(T = 1)Y †
pi(X)
− I(T = 0)Y
†
1− pi(X)
}
. (8)
This suggests that a standard IPW estimator based on the imputed outcome Y † has the
same limit asymptotically as if the true outcomes were used, even if imputation model (6)
is misspecified. Consequently the surrogate data from U could be safely used to impute the
outcome using a consistent estimator of Y †.
In practice pi(x) also needs to be estimated, which is typically done through parametric
modeling such as logistic regression. When pi(x) is estimated by an estimator pi(x), the
IPW estimator discussed above will be consistent for ∆ if pi(x) is consistent for pi(x) but
otherwise could be biased if the parametric model for pi(x) is misspecified. Alternatively,
similar arguments can be used to construct imputations Y † that could be substituted for Y
in an outcome regression estimator and still be robust to misspecification of the imputation
model. However, such an approach would then require correct specification of an outcome
regression model given baseline covariates for µk(x) to be consistent for ∆. In the following
we propose an IPW approach but weighting with a double-index PS (DiPS) (Cheng et al.,
2017). The resulting IPW estimator will be doubly-robust in that it will be consistent for
∆ when a model for either pi(x) or µk(x) is correctly specified. Whereas Cheng et al. (2017)
considered only the scenario where Y is fully observed, the present paper uses the double-
index PS to develop a novel ATE estimator in the SS setting. Using the double-index PS is
not essential in that an augmented IPW estimator (Robins et al., 1994, 1995) can potentially
be used to achieve double-robustness as well. We use the double-index PS for the clarity of
the construction, which directly follows the line of reasoning of the robust imputations.
2.4 Doubly-Robust IPW Based on the Double-Index PS
Suppose we postulate the following working parametric models for pi(x) and µk(x):
pi(X) = gpi(α0 +α
T
1 X) = pi(X;α) (9)
µT (X) = gµ(β0 + β
T
1 X + β2T ) = µT (X;β), (10)
where α = (α0,α
T
1 )
T, β = (β0,β
T
1 , β2)
T, and gpi(·) and gµ(·) are specified link functions. We
estimate α and β using regularized estimators:
α̂ = argmin
α
{
−N−1
N∑
i=1
`pi(α; Xi, Ti) + pλN (α1)
}
(11)
β̂ = argmin
β
{
−n−1
n∑
i=1
`µ(β;Yi,Xi, Ti) + pλn(β{−1})
}
, (12)
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where `pi(α; Xi, Ti) and `µ(β;Yi,Xi, Ti) are the log-likelihood contributions for the i-th
observation, and pλN (·) and pλn(·) are penalty functions chosen such that the oracle properties
(Fan and Li, 2001) hold. Examples of such estimators include the adaptive least absolute
shrinkage and selection operator (ALASSO) (Zou, 2006) where pλ(u) = λ
∑p
j=1 |uj| / |w˜j|
with initial weights w˜j estimated from ridge regression and tuning parameters are such that
NλN → ∞,
√
NλN → 0, nλn → ∞, and
√
nλn → 0. We then calibrate the initial PS
estimate pi(x; α̂) by the following kernel smoothing estimator:
pi(x; α̂1, β̂1) =
N−1
∑N
j=1 Kh(Ŝj − ŝ)I(Tj = 1)
N−1
∑N
j=1 Kh(Ŝj − ŝ)
,
where Ŝj = (α̂1, β̂1)
TXj and ŝ = (α̂1, β̂1)
Tx are bivariate scores that represent the covariate
in the directions of α̂1 and β̂1, Kh(·) = h−2K(·/h), with K(·) being a bivariate q-th order
kernel with q > 2 and h = O(N−α) being a bandwidth for which a suitable choice of α is
discussed below. Finally, we define the proposed SSDR estimator as ∆̂ = µ̂1 − µ̂0 where:
µ̂1 =
{
N∑
i=1
I(Ti = 1)
pi(Xi; α̂1, β̂1)
}−1{ N∑
i=1
I(Ti = 1)Ŷ
†
i
pi(Xi; α̂1, β̂1)
}
(13)
and µ̂0 =
{
N∑
i=1
I(Ti = 0)
1− pi(Xi; α̂1, β̂1)
}−1{ N∑
i=1
I(Ti = 0)Ŷ
†
i
1− pi(Xi; α̂1, β̂1)
}
, (14)
with Ŷ †i = gξ(γ̂
TZpi,i) . Here ∆̂ substitutes the robust imputations based on the PS estimated
by the double-index PS Ŷ † into an IPW estimator weighted also with the double-index PS.
Had Y been fully observed such that Ŷ †i = Yi for i = 1, . . . , N , an IPW estimator based on
the double-index PS is doubly-robust in that it is consistent when a working model for either
pi(x) in (9) or for µk(x) in (10) is correctly specified (Cheng et al., 2017). We will show that
in the SS setting, using the double-index PS in this robust imputation approach maintains
this double-robustness property.
2.5 Asymptotic Robustness and Efficiency Properties of ∆̂
We show in Web Appendix B that, under the causal identification assumptions (2)-(4) and
mild regularity conditions, given that h = O(N−α) with α ∈ (1−β
2q
, β
2
∧ 1
4
) and n = O(N1−β)
with β ∈ ( 1
q+1
, 1), ∆̂ is doubly-robust so that:
∆̂−∆ = Op(n−1/2) (15)
when either the PS model pi(x;α) in (9) or the baseline outcome model µk(x;β) in (10)
is correctly specified. To characterize the large sample variability of ∆̂, we next show it is
asymptotically linear and identify its influence function. First define ∆¯ = µ¯1 − µ¯0, where:
µ¯1 = E
{
I(T = 1)Y †
pi(X; α¯1, β¯1)
}
and µ¯0 = E
{
I(T = 0)Y †
1− pi(X; α¯1, β¯1)
}
,
with pi(x; α¯1, β¯1) = P(T = 1 | α¯T1 X = α¯T1 x, β¯T1 X = β¯T1 x), α¯1 and β¯1 as the probability
limits of α̂1 and β̂1 regardless of model adequacy, and Y
† being defined as in (8) except
that pi(x) is replaced by pi(x; α¯1, β¯1). We show in Web Appendix B that, under the same
requirements for α and β, the influence function for ∆̂ is given by n1/2(∆̂k−∆¯k) = Ŵ1−Ŵ0,
where Ŵk = n1/2(µ̂k − µ¯k) for k = 0, 1 and:
Ŵk = n−1/2
n∑
i=1
(vTβ1,k + u
T
pa,pi,k)ϕβ1,i + u
T
γ,kϕγ,i + op(1), (16)
with vβ1,k = 0 when the PS model pi(x;α) is correctly specified and upa,pi,k = 0 when either
the PS model pi(x;α) or imputation model gξ(γ
Tzpi) without the utility covariate is correctly
specified. Here ϕβ1,i and ϕγ,i are influence functions for β̂1 and γ̂ such that n
1/2(β̂1− β¯1) =
n−1/2
∑n
i=1ϕβ1,i+op(1) and n
1/2(γ̂−γ¯) = n−1/2∑ni=1ϕγ,i+op(1). Accordingly, the first term
in (16) represents the contribution from estimating β1 in the baseline outcome model µk(x;β)
for the double-index PS appearing in the IPW weight and the utility covariate. The remaining
term represents the contribution from estimating γ in the imputation model gξ(γ
Tzpi). The
influence function does not include terms associated with the variability in estimating α in
the parametric PS or for smoothing in the double-index PS, as such contributions to the
expansion are of higher order when N  n in the SS setting.
In terms of efficiency, when the PS model pi(x;α) is correctly specified, the influence
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function in (16) simplifies so that:
n1/2(∆̂−∆) = n−1/2
n∑
i=1
(uγ,1 − uγ,0)Tϕγ,i + op(1),
where:
ϕγ,i =
[
E
{
Zpi,iZpi,ig˙ξ(γ¯
TZpi,i)
}]−1
Zpi,i
{
Yi − gξ(γ¯TZpi,i)
}
,
for g˙ξ(u) =
∂
∂u
gξ(u)
∣∣∣
u=u
. The centering of Yi around a model approximation of ξT (V) suggests
that ∆̂ should achieve efficiency gain over complete-case (CC) estimators, which neglect the
surrogates W. Let ∆¯∗ = E{µ1(X) − µ0(X)} be strictly a functional of the observed data
distribution not depending on identification assumptions (2)-(4) as in ∆. To characterize the
efficiency of ∆̂ in a more full context, we show in Web Appendix C that the semiparametric
efficiency bound for ∆¯∗ under an ideal SS model where the distribution of (VT, T )T is known
but the conditional distribution of Y given (VT, T )T is unrestricted, with respect to a class
of regular parametric submodels subject to mild regularity conditions, is E(ϕ2eff ), where:
ϕeff = Upi{Y − ξT (V)} (17)
is the efficient influence function. This efficiency bound is lower than or equal to the efficiency
bound in the fully nonparametric model where the distribution of (VT, T )T is unknown.
Furthermore, we show in Web Appendix C that ∆̂ indeed achieves the SS efficiency bound
when both the PS and imputation model, pi(x;α) and gξ(γ
Tzpi), are correctly specified
so that ∆̂ is locally semiparametric efficient. In this case, even though the distribution of
(VT, T )T is actually not known in our setup, the bound under the ideal SS model can
still be achieved because N  n. The correct specification of µk(x;β) is not required for
attaining the efficiency bound, as the bound does not involve µk(x), but its specification is
still important for double-robustness in case pi(x;α) is misspecified. The local efficiency of ∆̂
prompts favorable efficiency compared to CC and other SS estimators that traditionally have
sought to be efficient under non-SS nonparametric models where the distribution of (VT, T )T
is assumed to be unknown. In our SS setting, ∆̂ gains efficiency over these approaches by
taking advantage of the additional information from the large set of unlabeled data U . Even
when the working models are not exactly correct as in practice, we find that ∆̂ still achieves
substantial efficiency gains if the models are adequate approximations. In particular, µk(x;β)
and g(γTzpi) may not be compatible with one another if non-linear models such as logistic
regression are used for either working model. Nevertheless, we find in such cases that ∆̂ still
attains large efficiency gains over existing estimators when flexible basis functions are used in
gξ(γ
Tzpi) to more closely approximate ξk(v). We offer some more discussion on the efficiency
gains of ∆̂ under model misspecification in the Section 5. We next consider inference about
∆ based on ∆̂ through a perturbation resampling procedure.
2.6 Perturbation Resampling
Although the asymptotic variance for ∆̂ is specified through the influence function in (16),
a direct estimate is difficult because the influence functions involves complicated functionals
of the data distribution. We instead propose a simple perturbation resampling procedure
for inference. Let G = {Gi : i = 1, . . . , N} be non-negative iid random variables with unit
mean and variance that are independent of the observed data D . We first obtained perturbed
estimators of α and β:
α̂∗ = argmin
α
{
−n−1
n∑
i=1
`pi(α; Xi, Ti)Gi + p
∗
λN
(α1)
}
β̂
∗
= argmin
β
{
−n−1
n∑
i=1
`µ(β;Yi,Xi, Ti)Gi + p
∗
λn(β{−1})
}
,
where p∗λN (·) and p∗λn(·) are the corresponding penalties based on the perturbed data if
data-adaptive weights are used, such as for adaptive LASSO. This leads to the perturbed
double-index PS:
pi∗1(x; α̂
∗
1, β̂
∗
1) =
∑N
j=1Kh(Ŝ
∗
j − ŝ∗)I(Tj = 1)Gj∑N
j=1 Kh(Ŝ
∗
j − ŝ∗)Gj
,
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where Ŝj = (α̂
∗
1, β̂
∗
1)
TXj and ŝ
∗ = (α̂∗1, β̂
∗
1)
Tx are the perturbed bivariate scores. We then
obtain the perturbed estimator for γ, γ̂∗, as the solution to:
n−1
n∑
i=1
Zpi∗,i
{
Yi − gξ(γTZpi∗,i)
}
Gi + λnγ{−1} = 0,
where pi∗ specifies that the imputations use utility covariates that plug in pi∗(x; α̂1, β̂
∗
1).
Finally, we calculate the perturbed SSDR estimator as ∆̂
∗ = µ̂∗1 − µ̂∗0, where:
µ̂∗1 =
{
N∑
i=1
I(Ti = 1)Gi
pi(Xi; α̂1, β̂
∗
1)
}−1{ N∑
i=1
I(Ti = 1)Ŷ
∗
i Gi
pi(Xi; α̂1, β̂
∗
1)
}
and µ̂∗0 =
{
N∑
i=1
I(Ti = 0)Gi
1− pi(Xi; α̂1, β̂
∗
1)
}−1{ N∑
i=0
I(Ti = 0)Ŷ
∗
i Gi
1− pi(Xi; α̂1, β̂
∗
1)
}
,
with Ŷ ∗i = gξ(γ̂
∗TZpi∗,i). It can be shown based on arguments similar to those in Tian et al.
(2007) that the asymptotic distribution of n1/2(∆̂ − ∆¯) coincides with that of n1/2(∆̂∗ −
∆̂) | D . In this perturbation scheme, estimation of α, the double-index PS through kernel
smoothing, and the final IPW estimators µ̂∗1 and µ̂
∗
0 does not technically need to be perturbed
as they are estimated based on data from U , and their contributions to the asymptotic
variance is of higher order when N  n. However, we found that not perturbing these steps
can have some impact on the standard error estimation in finite samples if N is not yet very
large relative to n and chose to perturb these steps by default. We approximate the standard
error of ∆̂ based on the empirical standard deviation, or, as a robust alternative, the mean
absolute deviation (MAD), of a large number of samples of ∆̂∗ and construct confidence
intervals (CI) based on the empirical percentiles.
3. Simulations
We performed simulations to assess the finite samples bias and relative efficiency (RE) of our
proposed estimator (SSDR) compared to alternative estimators. In separate simulations we
also examined the performance of the perturbation procedure for inference based on SSDR. For
SSDR, we specified h(·) in the imputation model in (6) as natural cubic splines with 6 knots
specified at uniform quantiles. Natural cubic splines were also applied to Ûpi for additional
flexibility in the imputation model. Ridge regression with the tuning parameter chosen by
cross-validation on the deviance was used for regularization in (7), and adaptive LASSO with
initial weights estimated by ridge regression and tuning parameter chosen by minimizing a
modified BIC criteria (Minnier et al., 2011) in (11) and (12). A plug-in estimate was used
for the bandwidth in the smoothing for the double-index PS (Cheng et al., 2017). Prior to
smoothing the components of Ŝ were standardized and transformed by a probability integral
transform based on the normal cumulative distribution function to induce approximately
uniformly distributed inputs, which can improve finite-sample performance (Wand et al.,
1991). As we focused on binary outcomes, we specified gξ(u) = gpi(u) = gµ(u) = 1/(1 + e
−u)
for the working models in (6) and (10).
For comparison, we considered common CC ATE estimators (Lunceford and Davidian,
2004; Kang and Schafer, 2007), including the standard IPW estimator (CCIPW), outcome
regression estimator (CCREG), and the standard doubly-robust estimator (CCDR). We also
considered two estimators that leverage U . The first is a naive imputation approach (SSNaive),
in which Y is imputed using a logistic regression of Y on V and T , and the imputations are
plugged into a standard IPW estimator. The second is adapted from a principled estimator
for pretest-posttest randomized studies with Y missing at random (SSPrePost) (Davidian et al.,
2005). We modified the estimator by replacing instances of the randomization probability by
PS estimates pi(Xi; α̂). SSPrePost is also doubly-robust so that it is consistent for ∆ when either
the PS model pi(x;α) or baseline outcome model µk(x;β) is correctly specified, providing
another approach to leverage U without requiring correct specification of an imputation
model. However, SSPrePost is constructed to achieve the efficiency bound in a model where
the distribution of (VT, T )T is unknown and Y is missing at random with the missingness
proportion bounded away from 0. This bound differs from that of the SS model we consider,
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and the RE simulations correspondingly show that SSDR is more efficient under a SS setup.
For all reference methods, the same logistic regression models with main effects only were
used for the underlying requisite PS, baseline outcome, and imputation models.
To mimic the EMR data, we considered the case with Y as binary and W as count
variables. In all scenarios, data were generated according to X ∼ N {0, σ2x(1− ρx)I + σ2xρx},
T | X ∼ Bernoulli {pi(X)}, Y | X, T ∼ Bernoulli{µT (X)}, and W = bΓ(1,XT, T, Y )T + c,
where  ∼ N{0, σ2w(1 − ρw)I + σ2wρw} and b·c is the floor function. We considered px = 10
baseline covariates and pw = 5 surrogates, with variances and correlations σ
2
x = 1, ρx = .2,
σ2w = 5, ρw = .2, and Γ5×13 = (05×1, .115×5,−.115×5, .115×1, (5, 5, 2.5, 0, 0)T). We varied
the simulations over different model specifications and sample sizes. The imputation model
was misspecified across all settings, whereas three scenarios were considered for the baseline
outcome model µk(x;β) and the PS model pi(x;α): (1) both models are correctly specified,
(2) the PS model is correctly specified but outcome model is misspecified, and (3) the outcome
model is correctly specified but the PS model is misspecified. The true pi(x) and µk(x) for
these three settings were specified as:
(1)Both correct: µk(x) = gµ(β0 + β
T
1 x + β2k), pi(x) = gpi(α0 +α
T
1 x)
(2)Misspecified µ: µk(x) = gµ
{
β0 + β
T
1[1]x(β
T
1[2]x + 1) + β2k
}
, pi(x) = gpi(α0 +α
T
1 x)
(3)Misspecified pi: µk(x) = gµ(β0 + β
T
1 x + β2k), pi(x) = gpi
{
α0 +α
T
1[1]x(α
T
1[2]x + 1)
}
,
where gµ(u) = gpi(u) = 1/(1 + e
−u) and parameter values were:
α0 = −.3, α1 = .3511×10, β0 = −.65, β1 = (111×3, .511×3,−1.15,−111×3)T
α1[1] = .5(0, .35, 0, .35, 0, .35, 0, .35, 0, .35)
T, α1[2] = (.35, 0, .35, 0, .35, 0, .35, 0, .35, 0)
T
β1[1] = .5(1, 0, 1, 0, .5, 0,−.5, 0,−1, 0)T, β1[2] = (0, .5, 0, .5, 0, .5, 0, .5, 0, .5)T.
We considered sample sizes of (A) n = 100 with N = 1, 112, (B) n = 250 with N = 5, 000,
and (C) n = 500 with N = 125, 000. The results in each scenario are summarized from 1,000
simulated datasets.
Table 1 presents the bias and root-mean square error (RMSE) across misspecification
scenarios. SSDR, SSPrePost, and CCDR exhibits low bias that diminishes to zero as sample
size increased under all three scenarios, demonstrating their double-robustness. In contrast,
CCREG and CCIPW exhibit substantial bias when working models µk(x;β) and pi(x;α) are
misspecified, respectively. SSNaive requires correct specification of both the imputation model
gξ(γ
Tzpi) and PS model pi(x;α) for consistency but shows negligible bias when both µk(x;β)
and pi(x;α) are correctly specified, as the logistic regression imputation model likely provides
an adequate approximation under the given data generating process. Still, it incurs sub-
stantial bias if either pi(x;α) or µk(x;β) are misspecified, where gξ(γ
Tzpi) becomes further
misspecified in the later case.
[Table 1 about here.]
Figure 1 presents the RE of various estimators relative to CCDR across different scenarios.
In the small sample case where n = 100 and N = 1, 112, SSDR is much more efficient than
both the CC and other SS estimators, regardless of the specification scenario. It gains over
the other SS estimators since its asymptotic variance approximates the SS efficiency bound
and through the use of regularization to estimate nuisance parameters. The efficiency gain
is most prominent under misspecification of µk(x;β), which may be driven by the lack of
impact on the influence function by µk(x;β) when pi(x;α) is correctly specified. In the large
sample case where n = 500 and N = 125, 000, SSDR is still uniformly most efficient, but the
gains are somewhat less pronounced. This is expected at least in part from the reduced role of
regularization in large samples. Though SSNaive may appear to be competitive in large samples
if pi(x;α) is correctly specified, it may suffer drastic efficiency loss from misspecification of
its imputation model under other data generating processes.
[Figure 1 about here.]
To implement the perturbation procedure, we used the weights Gi ∼ 4×Beta(.5, 1.5) and
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1,000 sets of G for SE and CI estimation. We considered evaluating the perturbations only
in the scenario where both µk(x;β) and pi(x;α) were correctly specified models. The results
are presented in Table 2. In small samples, SEs estimated by the standard deviation tended
to over-estimate due to the presence of outlying perturbed estimates, while SEs estimated by
MAD tended to under-estimate. In larger samples, the SE estimation improves. The coverage
probabilities are close to nominal levels but slightly under-cover in the sample sizes consid-
ered. In other simulations not reported we found that perturbation with weights sampled
from a multinomial distribution of size N and N categories with equal probabilities, which
effectively implements the bootstrap, to exhibit improved coverage probabilities. However,
justifying the bootstrap may be more involved due to the correlated weights.
[Table 2 about here.]
4. EMR Data Application
We applied SSDR and the alternative estimators to compare the rates of treatment response
to two biologic agents for treating patients with inflammatory bowel disease (IBD) using
the EMRs of two large metropolitan academic medical centers. Though the efficacy and
effectiveness of adalimumab (ADA) and infliximab (IFX) for the management of IBD have
been established individually, few studies have offered a direct comparison. Consequently
the choice of treatment in practice is often influenced by factors other than comparative
performance (Ananthakrishnan et al., 2016). Randomized trials may be unfeasible due to
the large number of patients that would be needed to detect the presumed small treatment
difference, and other observational data lack clinical information needed to ascertain mean-
ingful outcomes and covariates for adjustment. EMRs are thus uniquely positioned to provide
evidence on the comparative effectiveness of these two therapies.
The data we considered consisted of N = 1, 243 total IBD patients, including 200 who initi-
ated treatment with ADA and 1043 with IFX. Through chart review by a gastroenterologist,
a random subset of n = 117 records were labeled with the true treatment response status
(responder vs. non-responder) within one year of treatment initiation. We included 12 base-
line covariates to adjust for confounding in X, including demographics, comorbidities, prior
utilization, and inflammation biomarker levels. We also selected 35 post-treatment surrogates
for W, comprising of counts of NLP mentions of clinically relevant terms (e.g. “bleeding”,
“fistula”, “tenesmus”) within one year of initiation. The transformation u 7→ log(1 + u) was
applied to all count variables in V to mitigate instability in the estimation due to skewness
in their distributions. Nonparametric bootstrap was used to estimate SEs and CIs for the
alternative estimators and perturbation for SSDR, using the MAD of resampled estimates
as an robust estimator of the SEs. In addition we calculated two-sided p-values based on
inverting percentile CIs from the resampled estimates, using the well-known equivalence
between significance tests and confidence sets (Liu and Singh, 1997; Davison et al., 2003).
As shown in Table 3, the point estimates of most estimators agreed that patients receiving
ADA experienced lower rates of treatment response, after adjustment for confounding. SSDR is
estimated to achieve more than 600% efficiency gain over CC estimators and 450% efficiency
gain over the other SS estimators based on the estimated variances. It is the only estimator
that exhibits a difference that is significant at the .05 level, suggesting that patients receiving
IFX experience a modest benefit in the rate of response.
[Table 3 about here.]
5. Discussion
The lack of direct observation on gold-standard outcomes of interest makes it challenging to
perform CER using EMR data. Under a SS setting where the true outcome is labeled for
only a small subset of patients, we developed an efficient and robust estimator for the ATE
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that addresses the missingness in the outcome and confounding bias. The estimator adopts
an imputation approach to leverage surrogate data from U to improve efficiency. It is not
only robust to misspecification of the imputation model but also possesses the traditional
doubly-robust property, requiring only correct specification of either a PS or baseline outcome
model to be consistent. We showed that it is locally semiparametric efficient under an ideal
SS semiparametric model and demonstrated through simulations that it is more efficient than
available CC and alternative SS estimators, even under misspecification of working models.
The efficiency gain over CC estimators under a nonparametric model is not obvious if
the imputation model is badly misspecified. In a favorable scenario for CC estimators, at
distributions of the data for which pi(x;α) and µk(x;β) are correctly specified so that efficient
CC estimators under the nonparametric model are available and yet gξ(γ
Tzpi) is misspecified,
it can be shown by comparing the asymptotic variances that ∆̂ will still be more efficient
if E[U2pi{Y − gξ(γ¯TZpi)}{gξ(γ¯TZpi) − µT (X;β)}] = 0. This condition can be guaranteed,
for example, if linear link functions are used for gξ(·) and gµ(·), and each model includes
interactions between U2pi and its linear predictor. Another potential approach is to include
U2pi,iµTi(Xi; β̂) among the covariates of the imputation model and to introduce a more general
parameterization of the imputation model given by gξ,ρ(γ
TZpi) such that ρ is a parameter
enforcing E[U2pi{Y − gξ,ρ(γ¯TZpi)}gξ,ρ(γ¯TZpi)] = 0 at some ρ = ρ0.
We have assumed that the true outcomes Y are labeled completely at random, which
is usually reasonable since researchers can control the labeling. This assumption could be
restrictive if labeling was stratified by some known factors or if some records that are available
were not labeled for research purposes, in which case the labeling decision may not have
been random. One possible approach to address the case where Y are missing at random is
to apply weighting or semiparametric efficient methods (Robins et al., 1994, 1995; Robins
and Rotnitzky, 1995) to the estimating equation when estimating γ in (7). The working
imputation model gξ(γ
Tzpi) in (6) was specified as a main effects model for simplicity, but
interactions between h(V) and T could be directly included without difficulty. Interaction
effects between X and T can also be accommodated in the baseline outcome model µk(x;β)
in (10) when estimating the double-index PS by estimating the double-index PS separately
by treatment groups (Cheng et al., 2017). In the case where W is high dimensional, group
LASSO (Yuan and Lin, 2006) where the basis expansion functions for each surrogate variable
are grouped together can also potentially be used to improve efficiency in finite-samples. It
would also be of interest to extend the theoretical results to the case where px and pw are
allowed to diverge with n.
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In the following, the supporting lemmas of Web Appendix A identify rates of convergence
for frequently encountered quantities and also identify the efficient influence function for ∆¯∗
under a fully nonparametric model. The results in Web Appendix B show that ∆̂ is consistent
and asymptotically linear, deriving its influence function. The results in Web Appendix C
establish the semiparametric efficiency bound under the SS model and shows that ∆̂ achieves
this bound at particular distributions for the data so that it is locally semiparametric efficient.
Throughout these Web Appendices we assume that mild regularity conditions required for
the double-index PS in Web Appendix A of Cheng et al. (2017) hold.
The following notations facilitate the subsequent derivations. Let pik(x) = P(T = k | X =
x) for k = 0, 1. Let pik(x;α1,β1) = P(T = k | αT1 X = αT1 x,βT1 X = βT1 x), pik(x;α) =
pi(x;α)k{1− pi(x;α)}1−k, and pik(x;α1,β1) = pi(x;α1,β1)k{1− pik(x;α1,β1)}1−k for given
α1,β1 ∈ Rp and α ∈ Rp+1 and k = 0, 1. Moreover, let ϑ¯ = (α¯T1 , β¯T1 )T, ϑ̂ = (α̂T1 , β̂
T
1 )
T,
pik(x; ϑ¯) = pik(x; α¯1, β¯1), pik(x; ϑ¯) = pik(x; α¯1, β¯1), and pik(x; ϑ̂) = pik(x; α̂1, β̂1). Let the
working imputation model be denoted by ξT (V;γ, pi) = gξ{γT(1,h(V)T, T, Upi)T}, where
Upi = I(T = 1)/pi(X) − I(T = 0)/{1 − pi(X)}, given some PS pi . Let ωk,i = I(Ti =
k)/pik(Xi), ω¯k,i = I(Ti = k)/pik(Xi, ϑ¯), ω̂k,i = I(Ti = k)/pik(Xi, ϑ̂), and S¯ = (α¯1, β¯1)
TX
with S¯i = (α¯1, β¯1)
TXi, for k = 0, 1 and i = 1, . . . , N .
Web Appendix A: Supporting Lemmas
Lemma 1: The rates of uniform convergence for kernel estimators we use are as follows:
sup
x
∥∥pik(x; ϑ¯)− pik(x; ϑ¯)∥∥ = Op(a˜N) (A.1)
sup
x
∥∥∥∥ ∂∂αT1 pik(x; ϑ¯)− ∂∂αT1 pik(x; ϑ¯)
∥∥∥∥ = Op(b˜N) (A.2)
sup
x
∥∥∥∥ ∂∂βT1 pik(x; ϑ¯)− ∂∂βT1 pik(x; ϑ¯)
∥∥∥∥ = Op(b˜N) (A.3)
sup
x
∥∥∥pik(x; ϑ̂)− pik(x; ϑ¯)∥∥∥ = Op(an), (A.4)
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where:
a˜N = h
q +
(
logN
Nh2
)1/2
, b˜N = h
q +
(
logN
Nh4
)1/2
, and an = n
−1/2 + n−1/2b˜N + a˜N .
Proof. The uniform rates for fixed α¯1 and β¯1 in the first three equations follow directly
from the uniform convergence rates of kernel smoothers and their first derivatives (Hansen,
2008). To establish the uniform convergence rate for DiPS, we first note that:
sup
x
∥∥∥pik(x; ϑ̂)− pik(x; ϑ¯)∥∥∥ 6 sup
x
∥∥∥pik(x; ϑ̂)− pik(x; ϑ¯)∥∥∥+ sup
x
∥∥pik(x; ϑ¯)− pik(X; ϑ¯)∥∥ .
The first term on the right-hand side can be written:
sup
x
∥∥∥pik(x; ϑ̂)− pik(x; ϑ¯)∥∥∥
6 sup
x
∥∥∥∥ ∂∂αT1 pik(x; α¯1, β¯1)(α̂1 − α¯1) + ∂∂βT1 pik(x; α¯1, β¯1)(β̂1 − β¯1)
∥∥∥∥
+ sup
x
∥∥∥∥{ ∂∂αT1 pik(x; α¯1, β¯1)− ∂∂αT1 pik(x; α¯1, β¯1)
}
(α̂1 − α¯1)
∥∥∥∥
+ sup
x
∥∥∥∥{ ∂∂βT1 pik(x; α¯1, β¯1)− ∂∂βT1 pik(x; α¯1, β¯1)
}
(β̂1 − β¯1)
∥∥∥∥
+Op(‖α̂1 − α¯1‖2 +
∥∥∥β̂1 − β¯1∥∥∥2 + ‖α̂1 − α¯1‖∥∥∥β̂1 − β¯1∥∥∥).
We obtain the desired rate by collecting terms and applying the other rates from above,
using that ∂
∂αT1
pik(x; α¯1, β¯1) and
∂
∂βT1
pik(x; α¯1, β¯1) are continuous in x, and x lies in a compact
covariate space.
Lemma 2: Let ζi = g(Zi) be some integrable function of Zi = (V
T
i , Ti)
T, for i = 1, . . . , N .
Then:
N−1
N∑
i=1
ω̂k,iζi = E (ω¯k,iζi) +Op(cn), (A.5)
where cn = a˜N + n
−1/2N−1h−3.
Proof. Consider the decomposition:
N−1
N∑
i=1
ω̂k,iζi = S1,k + S2,k + S3,k,
where:
S1,k = N−1
N∑
i=1
ω¯i,kζi, S2,k = N−1
N∑
i=1
{
1
pik(Xi; ϑ¯)
− 1
pik(Xi; ϑ¯)
}
I(Ti = k)ζi,
and S3,k = N−1
N∑
i=1
{
1
pi(Xi; ϑ̂)
− 1
pik(Xi; ϑ¯)
}
I(Ti = k)ζi.
The second term can be bounded:
|S2k| 6 sup
x
∥∥pik(x; ϑ¯)− pik(x; ϑ¯)∥∥N−1 N∑
i=1
I(Ti = k)ζi
pik(Xi; ϑ¯)pik(Xi; ϑ¯)
= Op(a˜N).
The third term can be written:
S3,k = N−1
N∑
i=1
∂
∂αT1
I(Ti = k)ζi
pik(Xi; α¯1, β¯1)
(α̂1 − α¯1) + ∂
∂βT1
I(Ti = k)ζi
pik(Xi; α¯1, β¯1)
(β̂1 − β¯1)
+Op
(
‖α̂1 − α¯1‖2 +
∥∥∥β̂1 − β¯1∥∥∥2 + ‖α̂1 − α¯1‖∥∥∥β̂1 − β¯1∥∥∥)
= Op
{
(1 +N−1/2h−1 +N−1h−3)n−1/2
}
where we use that ∂
∂αT1
1/pik(Xi;α1,β1) and
∂
∂αT1
1/pik(Xi;α1,β1) are Lipshitz continuous in
α1 and β1 for the first equality and the rate deduced from an analogous term in Cheng et al.
(2017) for the second equality. The desired result follows from collecting the dominant rates.
Lemma 3: Let Y †i = ξTi(Vi; γ¯, pi) for i = 1, . . . , N . Then:
√
n
N
N∑
i=1
ω̂k,i(Y
†
i − µ¯k) = Op(1 + dn), (A.6)
where dn = ν
1/2
n N1/2hq + ν
1/2
n N−1/2h−2 +N−1/2h−1 +N−1h−3.
Proof. Consider the decomposition:
√
n
N
N∑
i=1
ω̂k,i(Y
†
i − µ¯k) = W˜1,1,k + W˜2,1,k + W˜3,1,k,
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where:
W˜1,1,k =
√
n
N
N∑
i=1
ω¯k,i(Y
†
i − µ¯k)
W˜2,1,k =
√
n
N
N∑
i=1
{
1
pik(Xi; ϑ¯)
− 1
pik(Xi; ϑ¯)
}
I(Ti = k)(Y
†
i − µ¯k)
W˜3,1,k =
√
n
N
N∑
i=1
{
1
pik(Xi; ϑ̂)
− 1
pik(Xi; ϑ¯)
}
I(Ti = k)(Y
†
i − µ¯k).
The first term is a scaled sum of iid centered terms so that:
W˜1,1,k = ν1/2n N−1/2
N∑
i=1
ω¯k,i(Y
†
i − µ¯k) = ν1/2n Op(1).
The V-statistic arguments similar to Cheng et al. (2017), the second term can be written:
W˜2,1,k = −ν1/2n N−1/2
N∑
i=1
E(Y †i | S¯i, Ti = k)
{
I(Ti = k)
pik(Xi; ϑ¯)
− 1
}
+Op
{
ν1/2n (h
q +N−1/2h−2)
}
+Op
{
ν1/2n (h
q +N1/2hq +N−1/2h−2)
}
+Op(ν
1/2
n N
1/2a˜2N)
= Op(ν
1/2
n N
1/2hq + ν1/2n N
−1/2h−2).
The final term can be written:
W˜3,1,k =
√
n
N
N∑
i=1
∂
∂αT1
I(Ti = k)(Y
†
i − µ¯k)
pik(Xi; α¯1, β¯1)
(α̂1 − α¯1) + ∂
∂βT1
I(Ti = k)(Y
†
i − µ¯k)
pik(Xi; α¯1, β¯1)
(β̂1 − β¯1)
+Op
{
n1/2
(
‖α̂1 − α¯1‖2 +
∥∥∥β̂1 − β¯1∥∥∥2 + ‖α̂1 − α¯1‖∥∥∥β̂1 − β¯1∥∥∥)}
= Op(1 +N
−1/2h−1 +N−1h−3)Op(1).
where we use that ∂
∂αT1
1/pik(Xi;α,β) and
∂
∂αT1
1/pik(Xi;α,β) are Lipshitz continuous in α
and β for the first equality and used the rate deduced from an analogous term from Cheng
et al. (2017) for the second equality. The desired result follows from collecting the rates.
Lemma 4: Let MNP = {fY,Z(y, z) : there exists a pi > 0 such that pi1(x) ∈ [pi, 1 −
pi] for all x where fX(x) > 0} be a nonparametric model for the distribution of (Y,Z), where
z = (vT, t)T. Let MNP,sub = {fY,Z(y, z; θ) : θ ∈ Θ} denote a regular parametric submodel of
MNP , where θ is a finite-dimensional parameter and the true density is at θ = θ∗. Let PNP
be the collection of all such regular parametric submodels that satisfy:
(1) Eθ[Eθ∗(Y | X, T = k)2] is continuous in θ at θ = θ∗ for k = 0, 1, where Eθ(·) and Eθ(· | ·)
denote expectation and conditional expectation with respect to f(·; θ) and f(· | ·; θ)
(2) The score at θ∗, satisfies SY,W,T,X(θ∗) = SY |W,T,X(θ∗) +SW|T,X(θ∗) +ST |X(θ∗) +SX(θ∗),
where SY |W,T,X(θ∗), SW|T,X(θ∗), ST |X(θ∗) and SX(θ∗) denote the scores in implied para-
metric submodels for the respective conditional and marginal distributions at θ∗.
(3) ∂
∂θ
Eθ∗{Eθ(Y | X, T = k)}
∣∣∣
θ∗
= Eθ∗{ ∂∂θEθ(Y | X, T = k)
∣∣∣
θ∗
} and Eθ∗ [ ∂∂θEθ∗{Eθ(Y |
W,X, T = k) | X, T = k}
∣∣∣
θ∗
] = Eθ∗ [Eθ∗{ ∂∂θEθ(Y | W,X, T = k)
∣∣∣
θ∗
| X, T = k}] for
k = 0, 1.
(4) Eθ{Eθ∗(Y |W,X, T = k)2 | X, T = k} is continuous in θ at θ∗ for k = 0, 1.
(5) Eθ(Y 2 |W,X, T = k) is continuous in θ at θ∗ for k = 0, 1.
The efficient influence function for ∆¯∗ = E{E(Y | X, T = 1) − E(Y | X, T = 0)} in MNP
with respect to PNP is:
Ψeff = E(Y | X, T = 1)− E(Y | X, T = 0) + {I(T = 1)
pi1(X)
− I(T = 0)
pi0(X)
}{Y − E(Y | X, T )} − ∆¯∗.
The semiparametric efficiency bound for ∆¯∗ under MNP with respect to PNP is E(Ψ2eff ).
Proof. The derivation of the semiparametric efficiency bound for ∆¯∗ underMNP directly
follows arguments from the well-known works of Robins et al. (1994) and Hahn (1998). It
can be shown that the availability of W in our framework does not alter the bound asMNP
is a model for the distribution of data where Y is fully observed. We omit repeating the
arguments here for brevity.
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Web Appendix B: Consistency and Asymptotic Linearity of ∆̂
Theorem 1: Under the identification assumptions from (2)-(4) of the main text, given
a bandwidth of h = O(N−α) for 1−β
2q
< α < min(β
2
, 1
4
) and n = O(N1−β) with 1
q+1
< β < 1,
∆̂−∆ = Op(n−1/2) when either pi1(x;α) or µk(x;β) is correctly specified.
Proof. We first show that ∆̂ − ∆¯ = Op(n−1/2) where ∆¯ = µ¯1 − µ¯0. If this can be shown,
the limiting estimate is:
∆¯ = E
{
I(T = 1)Y
pi1(X; ϑ¯)
− I(T = 0)Y
pi0(X; ϑ¯)
}
= ∆,
where the first equality follows from the argument in the main text and the second equality
holds when either pi1(x;α) or µk(x;β) are correctly specified (Cheng et al., 2017). It suffices
to show that µ̂k− µ¯k = Op(n−1/2) , for k = 0, 1. First note that the normalizing constant can
effectively be ignored. By application of Lemma 2 with ζi = 1, the normalizing constant is:
N−1
N∑
i=1
ω̂k,i = 1 +Op(cn). (A.7)
We can now write the standardized mean for the k-th group as:
n1/2(µ̂k − µ¯k) =
√
n
N
N∑
i=1
ω̂k,i(Ŷ
†
i − µ¯k) +
{N−1 N∑
i=1
ω̂k,i
}−1
− 1
 √n
N
N∑
i=1
ω̂k,i(Ŷ
†
i − µ¯k)
=
√
n
N
N∑
i=1
ω̂k,i(Ŷ
†
i − µ¯k) +Op(cn), (A.8)
where the last equality follows provided that the main term is Op(1). Denote:
W˜k =
√
n
N
N∑
i=1
ω̂k,i(Ŷ
†
i − µ¯k).
This can be decomposed as W˜k = W˜1,k + W˜2,k, where:
W˜1,k =
√
n
N
N∑
i=1
ω̂k,i(Y
†
i − µ¯k) and W˜2,k =
√
n
N
N∑
i=1
ω̂k,i(Ŷ
†
i − Y †i ). (A.9)
First, focusing on W˜2,k, we expand Ŷ †i = ξTi(Vi; γ̂, pi) around Y †i = ξTi(Vi; γ¯, pi):
W˜2,k = W˜pi2,k + W˜γ2,k +Op
{
sup
x
∥∥∥pi(x; ϑ̂)− pi(x; ϑ¯)∥∥∥2}+Op(‖γ̂ − γ¯‖2), (A.10)
where
W˜pi2,k =
√
n
N
N∑
i=1
ω̂k,i
∂
∂pi
ξTi(Vi; γ¯, pi)
{
pik(Xi; ϑ̂)− pik(Xi; ϑ¯)
}
(A.11)
accounts for estimating the DiPS in the imputation with ∂
∂pi
ξTi(Vi; γ¯, pi) = g˙ξ(γ¯
TZpi,i)[γ¯3{− I(Ti=1)pik(Xi;ϑ¯)2−
I(Ti=0)
(1−pik(Xi;ϑ¯))2}] and g˙ξ(u) = dgξ(u)/du and
W˜γ2,k =
√
n
N
N∑
i=1
ω̂k,i
∂
∂γ
ξTi(Vi; γ¯, pi)(γ̂ − γ¯) +Op(sup
x
∥∥∥pi(x; ϑ̂)− pi(x; ϑ¯)∥∥∥ ‖γ̂ − γ¯‖) (A.12)
accounts for estimating γ in the imputation. We can further decompose W˜pi2,k = W˜pa,pi2,k +
W˜np,pi2,k , where:
W˜pa,pi2,k =
√
n
N
N∑
i=1
ω̂k,i
∂
∂pi
ξTi(Vi; γ¯, pi)
{
pik(Xi; ϑ̂)− pik(Xi; ϑ¯)
}
W˜np,pi2,k =
√
n
N
N∑
i=1
ω̂k,i
∂
∂pi
ξTi(Vi; γ¯, pi)
{
pik(Xi; α¯1, β¯1)− pik(Xi; ϑ¯)
}
. (A.13)
The W˜pa,pi2,k term accounts for the parametric estimation of α1 and β1 in DiPS and is:
W˜pa,pi2,k =
√
n
N
N∑
i=1
ω̂k,i
∂
∂pi
ξTi(Vi; γ¯, pi)
{
∂
∂αT1
pik(Xi; α¯1, β¯1)(α̂− α¯)
+
∂
∂βT1
pik(Xi; α¯1, β¯1)(β̂ − β¯) +Op(‖α̂− α¯‖2 +
∥∥∥β̂ − β¯∥∥∥2 + ‖α̂− α¯‖∥∥∥β̂ − β¯∥∥∥)}
= N−1
N∑
i=1
ω̂k,i
∂
∂pi
ξTi(Vi; γ¯, pi)
{
∂
∂αT1
pik(Xi; α¯1, β¯1)n
1/2(α̂− α¯) + ∂
∂βT1
pik(Xi; α¯1, β¯1)n
1/2(β̂ − β¯)
}
+Op(1 + cn)Op(b˜N)Op(ν
1/2
n ) +Op(1 + cn)Op(b˜N)Op(1)
= Op(1 + cn) +Op(b˜N), (A.14)
where the first equality uses the Lipshitz continuity of K˙(·), the second equality applies
Lemma 1 and Lemma 2 taking ζi =
∂
∂pi
ξTi(Vi; γ¯, pi), and the last equality applies lemma 2
again taking ζi =
∂
∂pi
ξTi(Vi; γ¯, pi)
∂
∂αT1
pi(Xi; ϑ¯) as well as ζi =
∂
∂pi
ξTi(Vi; γ¯, pi)
∂
∂βT1
pi(Xi; ϑ¯).
The W˜np,pi2,k term accounts for the nonparametric smoothing in DiPS and can be bounded:
W˜np,pi2,k 6 n1/2 sup
x
∥∥pik(x; ϑ¯)− pik(x; ϑ¯)∥∥N−1 N∑
i=1
ω̂k,i
∂
∂pi
ξTi(Vi; γ¯, pi) (A.15)
= Op(n
1/2a˜N)Op(1 + cn) = Op(n
1/2a˜N). (A.16)
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Returning to (A.11), the following term accounts for the parametric estimation of γ:
W˜γ2,k = N−1
N∑
i=1
ω̂k,i
∂
∂γ
ξTi(Vi; γ¯, pi)n
1/2(γ̂ − γ¯) +Op(1 + cn)Op(an)Op(1)
= Op(1 + cn)Op(1) +Op(an) = Op(1 + cn + an), (A.17)
where the first equality applies Lemma 2 taking ζi =
∂
∂γ
ξTi(Vi; γ¯, pi)
∂
∂pi
ξTi(Vi; γ¯, pi) as well
as Lemma 1, and the second equality follows from application of Lemma 2 again taking
ζi =
∂
∂γ
ξTi(Vi; γ¯, pi). Finally, collecting all the terms, we find:
n1/2(µ̂k − µ¯k) = W˜1,k + W˜pa,pi2,k + W˜np,pi2,k + W˜γ2,k +Op(a2n + n−1) +Op(cn)
= Op(1 + dn) +Op(1 + cn + b˜N) +Op(n
1/2a˜N) +Op(1 + cn + an)
+Op(a
2
n + n
−1) +Op(cn)
= Op(1), (A.18)
where the second to last equality applies Lemma 3 and the last equality follows when h =
O(N−α) for 1−β
2q
< α < min(β
2
, 1
4
) and n = O(N1−β) for 1
q+1
< β < 1. This shows that
µ̂k − µ¯k = Op(n−1/2).
Theorem 2: Let Ŵk = n1/2(µ̂k−µ¯k) for k = 0, 1 so that n1/2(∆̂−∆¯) = Ŵ1−Ŵ0. Given
a bandwidth of h = O(N−α) for 1−β
2q
< α < min(β
4
, 1
4
) and n = O(N1−β) with 1
q+1
< β < 1,
then Ŵk has the influence function expansion of the form:
Ŵk = n−1/2
n∑
i=1
(vTβ1,k + u
T
pa,pi,k)ϕβ1,i + u
T
γ,kϕγ,i + op(1), (A.19)
where vβ1,k = 0 when pi1(x;α) is correctly specified and upa,pi,k = 0 when either pi1(x;α) or
ξk(v;γ, pi) without the utility covariate is correctly specified.
Proof. As in (A.8) and (A.9) the standardized mean for the k-th group can be written:
Ŵk = W˜k +Op(cn) = W˜1,k + W˜2,k +Op(cn), (A.20)
where the first equality follows provided W˜k = Op(1). The first term can be written:
W˜1,k = ν1/2n N−1/2
N∑
i=1
ω̂k,i(Y
†
i − µ¯k)
= ν1/2n W˜1,1,k + ν1/2n W˜ct2,1,k +Op
{
ν1/2n (h
q +N1/2hq +N−1/2h−2 +N1/2a˜2N)
}
+
{
vTβ1,k +Op
(
N−1/2h−1 +N−1h−3
)}
n1/2(β̂1 − β¯1) +Op
{
ν1/2n (1 +N
−1/2h−1 +N−1h−3)
}
,
where:
W˜1,1,k = N−1/2
N∑
i=1
ω¯k,i(Y
†
i − µ¯k)
W˜ct2,1,k = −N−1/2
N∑
i=1
E(Y † | S¯, T = k) (ω¯k,i − 1) +Op(hq +N−1/2h−2)
vβ1,k = E
{
K˙h
(
S¯j − S¯i
h
)T
(1− ω¯k,i) I(Ti = k)(Y
†
i − µ¯k)
lk(Xi; ϑ¯)
(X†j −X†i )T
}
,
with lk(x; ϑ¯) = pik(x; ϑ¯)f(x; ϑ¯) and f(x; ϑ¯) being the joint density of S¯, and x
† = (x,0)
for any vector x. Here vβ1,k = Op(1) in general and is 0 when pi(X;α) is correctly specified
(Cheng et al., 2017). As in (A.10) and (A.13) of Theorem 1, the second term from (A.20)
can be written:
W˜2,k = W˜pa,pi2,k + W˜np,pi2,k + W˜γ2,k +Op(a2n + n−1).
Continuing the expansion of W˜pa,pi2,k from (A.14):
W˜pa,pi2,k = N−1
N∑
i=1
ω̂k,i
∂
∂pi
ξTi(Vi; γ¯, pi)
∂
∂βT1
pik(Xi; ϑ¯)n
1/2(β̂1 − β¯1) +Op
{
(1 + cn)(ν
1/2
n + b˜N)
}
= E
{
ω¯k,i
∂
∂pi
ξTi(Vi; γ¯, pi)
∂
∂βT1
pik(Xi; ϑ¯)
}
n1/2(β̂1 − β¯1) +Op
{
cn + (1 + cn)(ν
1/2
n + b˜N)
}
= n−1/2
n∑
i=1
uTpa,pi,kϕβ1,i + op(1) +Op(cn + b˜N),
by repeated application of Lemma 2, where:
uTpa,pi,k = E
{
ω¯k,i
∂
∂pi
ξTi(Vi; γ¯, pi)
∂
∂βT1
pik(Xi; ϑ¯)
}
(A.21)
is a constant that is 0T when either pik(x;α) or ξk(v;γ, pi) without the utility covariate is
correctly specified and ϕβ1,i is the influence function for β̂. For W˜
np,pi
2,k from (A.15) we have
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that W˜np,pi2,k = Op(n1/2a˜N). For W˜γ2,k, continuing from (A.17):
W˜γ2,k = N−1
N∑
i=1
ω̂k,i
∂
∂γ
ξTi(Vi; γ¯, pi)n
1/2(γ̂ − γ¯) +Op(an)
= E
{
ω¯k,i
∂
∂γ
ξTi(Vi; γ¯, pi)
}
n1/2(γ̂ − γ¯) +Op(cn)Op(1) +Op(an)
= n−1/2
n∑
i=1
uTγ,kϕγ,i + op(1) +Op(cn + an),
where:
uTγ,k = E
{
ω¯k,i
∂
∂γ
ξTi(Vi; γ¯, pi)
}
is some constant and ϕγi is the influence function for γ̂.
Collecting the results from above, we find:
Ŵk = n−1/2
n∑
i=1
(vTβ1,k + u
T
pa,pi,k)ϕβ1,i + u
T
γ,kϕγ,i +Op
{
ν1/2n (N
1/2hq +N−1/2h−2)
}
+Op(N
−1/2h−1 +N−1h−3 + b˜N + n1/2a˜N + cn + an)
= n−1/2
n∑
i=1
(vTβ1,k + u
T
pa,pi,k)ϕβ1,i + u
T
γ,kϕγ,i +Op
{
ν1/2n N
1/2hq +
(logN)1/2
N1/2h2
+ ν1/2n
(logN)1/2
h
}
.
The error terms are op(1) when h = O(N
−α) for 1−β
2q
< α < min(β
2
, 1
4
) and n = O(N1−β) for
1
q+1
< β < 1.
Web Appendix C: Semiparametric Efficiency
Theorem 3: Let MSS = {fY,Z(y, z) = fY |Z(y | z)f ∗Z(z) : f ∗Z(z) is a known density such
that there exists a pi > 0 where pi
∗
1(x) ∈ [pi, 1 − pi] for all x with f ∗X(x) > 0} be an ideal
semiparametric semi-supervised model where the distribution of Z = (VT, T )T is known, with
z = (vT, t)T and pi∗1(x) and f
∗
X(x) being the implied PS and density of X under f
∗
Z(z). Let
MSS,sub = {fY |Z(y, z; θ)f ∗Z(z) : θ ∈ Θ} denote a regular parametric submodel of MSS, where
θ is a finite-dimensional parameter, and the true density is at θ = θ∗. Let PSS ⊆ PNP be the
sub-collection of all such regular parametric submodels among PNP . The efficient influence
function for ∆¯∗ in MSS with respect to PSS is:
ϕeff =
{
I(T = 1)
pi1(X)
− I(T = 0)
pi0(X)
}
{Y − ξT (V)} , (A.22)
and the semiparametric efficiency bound for ∆¯∗ under MSS with respect to PSS is E(ϕ2eff ).
Furthermore, the efficiency bound under MSS is lower than or equal to the efficiency bound
under the fully nonparametric model MNP where the distribution of Z is unknown. That is,
E(ϕ2eff ) 6 E(Ψ2eff ).
Proof. Let L02 denote the Hilbert space of mean 0 square-integrable functions of (Y,ZT)T
at the true distribution, with inner product of v1, v2 ∈ L02 defined by 〈v1(Y,Z), v2(Y,Z)〉 =
E {v1(Y,Z)v2(Y,Z)}. We first show that the tangent space of MSS with respect to PSS at
the true distribution is the closure of {s(Y,Z) ∈ L02 : E{s(Y,Z) | Z} = 0}, denoted by ΛSS.
Let s(Y,Z) be any bounded element belonging to ΛSS. Consider the parametric submodel
given by MSS,tlt = {fY,Z(y, z; θ) = fY |Z(y | z; θ)f ∗z (z) : θ ∈ (−ε, ε)} for some sufficiently
small ε > 0, where:
fY |Z(y | z; θ) = f ∗Y |Z(y | z){1 + θs(y, z)}
with f ∗Y |Z(y | z) being the true density. The true density is thus at θ = θ∗ = 0. It can
be shown that MSS,tlt and the implied conditional and marginal submodels have proper
densities, are regular, and the respective score can be written as the derivative of the log
density with respect to θ. It can also be shown through calculations similar to those in
analogous arguments for the derivation of Lemma 4 that MSS,tlt belongs in PSS ⊆ PNP .
The score for MSS,tlt at θ = θ∗ = 0 is SY,Z(θ∗) = s(Y,Z), so any bounded element in
ΛSS belongs in the tangent space of MSS with respect to PSS at the true distribution.
Since the bounded elements are dense in ΛSS and the tangent space is closed, any element
r(Y,W, T,X) ∈ ΛSS also belongs in the tangent space. Any element of the tangent space at
the true distribution also belongs in ΛSS by the regularity of the parametric submodels and
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properties of scores. This verifies that the tangent space ofMSS with respect to PSS at the
true distribution is ΛSS.
We next show that Ψeff is one influence function for ∆¯
∗ in MSS at the true distribution
with respect to PSS. Recall from Lemma 4 that Ψeff is the unique influence function for
∆¯∗ in MNP with respect to PNP . This means that under any regular parametric submodel
MNP,sub belonging to PNP , Ψeff satisfies:
∂
∂θ
∆¯∗(θ)
∣∣∣
θ∗
= Eθ∗{ΨeffSY,W,T,X(θ∗)}.
Now since PSS ⊆ PNP , pathwise differentiability of ∆¯∗(θ) at θ = θ∗ also holds, in particular,
under any regular parametric submodel in PSS, with Ψeff being one influence function.
Finally, to obtain the efficient influence function for ∆¯∗ inMSS with respect to PSS at the
true distribution, we identify the orthogonal projection of Ψeff onto ΛSS. It can be verified
that this projection is Π(Ψeff | ΛSS) = Ψeff − E(Ψeff | Z). The efficient influence function
in MSS is thus:
ϕeff = Π(Ψeff | ΛSS) = Ψeff − E(Ψeff | Z)
= (E(Y | X, T = 1) + [I(T = 1)
pi1(X)
{Y − E(Y | X, T = 1)}])
− (E(Y | X, T = 0) + [I(T = 0)
pi0(X)
{Y − E(Y | X, T = 0)}])− ∆¯∗
− (E(Y | X, T = 1) + [I(T = 1)
pi1(X)
{E(Y | Z)− E(Y | X, T = 1)}])
+ (E(Y | X, T = 0) + [I(T = 0)
pi0(X)
{E(Y | Z)− E(Y | X, T = 0)}]) + ∆¯∗
= {I(T = 1)
pi1(X)
− I(T = 0)
pi0(X)
}{Y − E(Y | Z)}.
By the Pythagorean theorem, we can verify:
E(Ψ2eff ) = ‖Ψeff‖2L02 = ‖Π(Ψeff | ΛSS)‖
2
L02 + ‖Ψeff − Π(Ψeff | ΛSS)‖
2
L02
> ‖Π(Ψeff | ΛSS)‖2L02
= E(ϕ2eff ).
Corollary 1: Given a bandwidth of h = O(N−α) for 1−β
2q
< α < min(β
4
, 1
4
) and n =
O(N1−β) for 1
q+1
< β < 1, when pi1(x;α) and ξk(v;γ, pi) are correctly specified, then:
n1/2(∆̂− ∆¯∗) = n−1/2
n∑
i=1
Ui{Yi − ξTi(Vi)}+ op(1). (A.23)
That is, ∆̂ achieves the semiparametric efficiency bound in the ideal SS semiparametric model
where the distribution of Z is known.
Proof. From Theorem 2, given an appropriate bandwidth and order of labels, when pi1(x;α)
is correctly specified:
n1/2(∆̂− ∆¯∗) = n−1/2
n∑
i=1
(uTγ,1 − uTγ,0)ϕγ,i + op(1),
where:
uTγ,kϕγ,i = E
{
ωk,i
∂
∂γT
ξTi(Vi;γ, pi)
∣∣∣
γ=γ¯
}{
∂
∂γT
EZpi,iξTi(Vi;γ, pi)
∣∣∣
γ=γ¯
}−1
Zpi,i {Yi − ξTi(Vi; γ¯, pi)}
= E
{
ωk,iZ
T
pi,ig˙ξ(γ¯
TZpi,i)
}
E
{
Zpi,iZ
T
pi,ig˙ξ(γ¯
TZpi,i)
}−1
Zpi,i {Yi − ξTi(Vi; γ¯, pi)} .
The first and second equalities assume the usual regularity conditions to obtain the influence
function of an estimator that is the solution of an estimating equation and exchange order
of differentiation and integration. The influence function for ∆̂ can then be written as:
(uTγ,1 − uTγ,0)ϕγ,i = E
{
Upi,iZ
T
pi,ig˙(γ¯
TZpi,i)
}
E
{
Zpi,iZ
T
pi,ig˙(γ¯
TZpi,i)
}−1
Zpi,i {Yi − ξTi(Vi; γ¯, pi)} .
The terms involving Zpi,i is a population weighted least square projection of Ui onto Zi,
weighted by g˙(γ¯TZpi,i). But since Zpi,i includes Upi,i, the influence function simplifies:
(uTγ,1 − uTγ,0)ϕγ,i = Upi,i {Yi − ξTi(Vi; γ¯, pi)} = Upi,i {Yi − ξTi(Vi)} ,
where the second equality follows when ξk(v;γ, pi) is correctly specified.
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Figure 1. RE of estimators, defined as the ratio of mean square errors (MSE) relative to
CCDR, by model misspecification scenarios over 1,000 simulated datasets. Higher values of
RE denotes greater efficiency (lower MSE) relative to CCDR. Higher values of RE denotes
greater efficiency (lower MSE) relative to DR-CC.
Table 1
Bias and RMSE of estimators under different model misspecification scenarios over 1,000 simulated datasets.
Both Correct Misspecified µ Misspecified pi
Size Estimator Bias RMSE Bias RMSE Bias RMSE
n = 100,
N = 1112
CCIPW 0.008 0.235 0.012 0.296 0.014 0.126
CCREG -0.001 0.096 0.023 0.127 0.003 0.075
CCDR -0.001 0.118 0.014 0.190 0.002 0.075
SSNaive -0.004 0.104 0.012 0.115 0.017 0.068
SSPrePost -0.004 0.094 0.013 0.126 -0.002 0.068
SSDR -0.006 0.077 -0.005 0.083 0.000 0.048
n = 500,
N = 12500
CCIPW -0.001 0.115 0.004 0.117 0.020 0.060
CCREG 0.000 0.041 0.022 0.057 -0.002 0.029
CCDR -0.002 0.063 0.002 0.081 -0.002 0.029
SSNaive 0.001 0.029 0.009 0.038 0.018 0.027
SSPrePost 0.001 0.033 0.000 0.048 -0.002 0.021
SSDR -0.002 0.028 -0.001 0.037 -0.001 0.020
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Table 2
Performance of perturbation resampling for SSDR in 1,000 simulated datasets when both µk(x;β) and pi(x;α) are
correctly specified. Emp SE: empirical SE of SSDR over simulated datasets; ASE: average of estimated SE based on
the standard deviation of perturbed estimates; ASEMAD: average of SE based on MAD of perturbed estimates;
RMSE: root-mean square error; Coverage: coverage of 95% percentile CIs.
Size Bias Emp SE ASE ASEMAD RMSE Coverage
n = 100, N = 1112 -0.005 0.076 0.306 0.057 0.076 0.914
n = 250, N = 5000 -0.003 0.043 0.039 0.036 0.043 0.921
Table 3
Point and SE estimates based on MAD for the ATE of ADA vs. IFX, with respect to one-year treatment response
rate, among IBD patients in EMR data based on various methods, including the naive CC estimator (CCNaive) that
completely ignores confounding bias. 95% CIs are percentile-based CIs from resampling and p-values are for testing
H0 : ∆ = 0 based on inverting percentile CIs.
Estimator Estimate SE 95% CI (Pct) p-value
CCNaive 0.014 0.099 (-0.201, 0.177) 0.822
CCIPW -0.227 0.325 (-0.558, 0.164) 0.714
CCREG -0.067 0.123 (-0.273, 0.162) 0.732
CCDR -0.125 0.153 (-0.416, 0.164) 0.592
SSNaive -0.051 0.088 (-0.318, 0.065) 0.198
SSPrePost 0.033 0.109 (-0.265, 0.180) 0.778
SSDR -0.067 0.036 (-0.164, -0.002) 0.044
